Cosmetics reform legislation under consideration in the US could provide a number of benefits to industry – from renewed consumer faith in the safety of cosmetic products to possible preemption of state laws – but it also could raise significant new challenges for companies subject to inspections.
FDA's Linda Katz, director of the Office of Cosmetics and Colors, discussed the current inspection process May 18 at the Independent Cosmetic Manufacturers and